Abstract:Objective: To understand the changes in functional connectivity between brain areas of potential importance in migraine during different phases of the attack. Background: Migraine is a symptomatically heterogeneous disorder. Understanding the possible changes in brain function and, therefore, neurobiology during different phases of the migraine attack is important in developing disease biomarkers and advancing therapeutics. Design: Randomized, double-blind, placebo-controlled, multi-visit experimental study. Methods: Subjects aged 18-50 years with migraine with and without aura (≤22 headache days per month) were recruited from across the UK using advertising, from both population and hospital clinic samples (n = 53). Consented subjects were randomized to a 0.5 µg/kg/min nitroglycerin infusion or to placebo over 20 minutes across different study visits, during the period February 2015-July 2017.* All subjects were exposed to a nitroglycerin infusion at least on 1 occasion at screening.** For those subjects who consented to participate in imaging visits (n = 25), structural T1, T2 and FLAIR sequences and resting state blood oxygen level dependant contrast (rsBOLD) time series, using a multiecho EPI sequence, were conducted over 30-40 minutes at baseline and rsBOLD during premonitory symptoms and migraine headache on a 3T General Electric MR750 MRI scanner. For the placebo visit, the imaging was conducted at the same times following infusion in the absence of symptoms. Results: Montreal Neurological Institute (MNI) coordinates were used to characterize identified brain areas of connectivity change. Using repeated measures ANOVA models with time (visit number) and trigger substance (nitroglycerin/placebo) as factors, significant positive functional coupling was found between the thalami bilaterally and the right precuneus and cuneus regions during the nitroglycerin-triggered premonitory phase (T = 3.23, peak connectivity change at [-6, -68, 40] for left thalamus, P = 0.012 and [-4, -68, 40] for right thalamus, P = 0.019). The nitroglycerin-triggered premonitory phase was associated with a change in the direction of connectivity from positive to negative between the pons and the limbic lobe (T = 3.47, peak connectivity change at [2, 8, 50], P < 0.001). The headache phase of the nitroglycerin-triggered migraine attack was associated with ongoing negative functional coupling between the pons and the cingulate and frontal cortices, and positive functional coupling between the pons and the cerebellar tonsils and medulla (T = 3.47, peak connectivity change at [-8, -52, -58], P = 0.007). Conclusions: Understanding the functional reorganization between subcortical and cortical brain areas in different phases of the migraine attack provides novel insights into the abnormal sensory processing and integration during migraine, as well as functional correlation with clinical symptoms displayed during each phase. [*Correction added on July 22, 2020 after first online publication: This sentence was revised from, "Consented subjects had a 0.5 μg/kg/min nitroglycerin infusion…".] [**Correction added on July 22, 2020 after first online publication: This sentence was revised from, "… at least on 1 occasion at screening."].

Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks.

Alterations in Functional Connectivity During Different Phases of the Triggered Migraine Attack

Headache and non-headache symptoms provoked by nitroglycerin in migraineurs: A human pharmacological triggering study

Brain-wide mapping of c-Fos expression in nitroglycerin-induced models of migraine

PAR2 activation in the dura causes acute behavioral responses and priming to glyceryl trinitrate in a mouse migraine model

Assessment of Preclinical Cognition Impairment in Hypertension Patients with Functional Magnetic Resonance Imaging

Nitroglycerin as a comparative experimental model of migraine pain: From animal to human and back

The human NTG model of migraine in drug discovery and development

Migraine prodromes and migraine triggers

Ghrelin attenuated hyperalgesia induced by chronic nitroglycerin: CGRP and TRPV1 as targets for migraine management

Altered intra- and inter-network functional activity among migraine, chronic migraine, and trigeminal neuralgia

Comparative Efficacies of Antimigraine Drugs Using Nitroglycerin Induced Migraine Rats Model

Soluble guanylyl cyclase is a critical regulator of migraine-associated pain

Spontaneous migraine attack causes alterations in default mode network connectivity: a resting-state fMRI case report

Intervening in the Premonitory Phase to Prevent Migraine: Prospects for Pharmacotherapy

Effect of Nitroglycerin migraine model on brain immediately early gene expression and intervention effect of Flunarizine Hydrochloride

Sumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in mice

Botulinum Toxin Type A Reducing SP Immunoreactivity in Jugular Plasma,brain Stem and Ganglion Nervi Trigemini in Migraine Model Rats Triggered by Nitroglycerin

Calcitonin Gene-Related Peptide Modulates Heat Nociception in the Human Brain - An fMRI Study in Healthy Volunteers

Pre-treatment with new kynurenic acid amide dose-dependently prevents the nitroglycerine-induced neuronal activation and sensitization in cervical part of trigemino-cervical complex

Longitudinal changes in functional connectivity and pain-induced brain activations in patients with migraine: a functional MRI study pre- and post- treatment with Erenumab